Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Obesity-Related Cognitive Impairment: An Update Overview of Mechanisms and Treatments

Zhong C., Chen K., Lin S., Huang Y.

Narrative Review on Type 2 Diabetes, Neuroinflammation, published in Expert Rev Mol Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Expert Rev Mol Med (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42071306
PMCID
PMC13215715
DOI
10.1017/erm.2026.10049

Abstract (original English)

Background Lifestyle changes and unhealthy eating habits have led to a sharp rise in obesity rates worldwide. Obesity is closely associated with a range of complications, including cognitive impairment and dementia. Accumulating evidence indicates that obesity negatively affects cognitive function and may increase the risk of neurodegenerative diseases. Conversely, cognitive dysfunction may further contribute to the development and progression of obesity. With growing attention in this field, obesity-related cognitive impairment has emerged as an important research focus at the intersection of metabolic and neurological disorders. Methods This article reviews the potential mechanisms underlying obesity-related cognitive impairment and summarizes emerging therapeutic strategies. Results The development and progression of obesity-related cognitive impairment involve multiple mechanisms, including insulin resistance, systemic and central inflammation, immune dysregulation, microcirculatory alterations and changes in neurotransmitters and synaptic plasticity. Recent studies have focused on the adipose tissue-brain axis and the microbiota-gut-brain axis, in particular, the targeted effects of extracellular vesicles released from adipose tissue and microbiota on the brain. Conclusions This article systematically reviews the mechanisms underlying obesity-related cognitive impairment a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
BrainAdipose TissueAnimalsHumansObesityCognitive Dysfunction

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research